Home › Drug Codes › J Codes › J1105 · IGALMI
Updated October 1st, 2026

IGALMI J Code: J1105

Dexmedetomidine, oral, 1 mcg

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q4 2026
APC Payment Limit ?
Not published
CMS publishes none for Q4 2026
ASP ?
No current ASP
Not available for Q4 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
2
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Dexmedetomidine, oral, 1 mcg
HCPCS Added Date January 1, 2024
Manufacturer BioXcel Therapeutics
Route of Administration Sublingual
Generic Status Single-Source; Branded
Dosage Form Film

About IGALMI

Igalmi is a medication aligned to the HCPCS J Code: J1105 for billing, pricing, and reimbursement purposes in the United States. It is a Psychiatric drug administered via the sublingual route and manufactured by BioXcel Therapeutics.

Manufacturers, reach out to us to add more information.

NDC Code Information

2 NDC packages are crosswalked to J1105. Package detail is available to logged-in subscribers.

Login to view 2 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

IGALMI Pricing & Reimbursement

J1105 Private Payer Reimbursement
$13.11 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Dexmedetomidine 505(b)(2) Information:

HCPCS Code Manufacturer Active Ingredient HCPCS Description
J1105 BioXcel Therapeutics Dexmedetomidine Dexmedetomidine, oral, 1 mcg

IGALMI Medically Unlikely Edits (MUE)

The most billing units of J1105 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mcg.

Practitioner Office & Hospital Outpatient
360 units / day
= 360 mcg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mcg Enter a dose to see how many billing units it is and whether it is under the limit.
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

IGALMI Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

agitation associated with schizophrenia or bipolar I or II disorder
Drug Class
Adrenergic alpha2-Agonists [MoA]Central alpha-2 Adrenergic Agonist [EPC]General Anesthesia [PE]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Igalmi billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for IGALMI.
Are there any available Igalmi patient assistance programs?
IGALMI patient assistance information can be found through BIOXCEL THERAPEUTICS, INC.. Visit Here →
Where can I find Igalmi prescribing information?
IGALMI prescribing information can be found at the link below: Visit Here →
Where can I find Igalmi side effect information?
Information regarding IGALMI's side effects can be found at MedlinePlus Visit Here →
Does billing IGALMI require JZ/JW wastage modifiers?
CMS does not include IGALMI (J1105) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1105. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.